These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7529665

  • 21. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M, Fredholm BB, Lerner UH.
    Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
    [Abstract] [Full Text] [Related]

  • 22. Effects of nicardipine on pancreatic exocrine secretion in the dog.
    Iwatsuki K, Ikeda K, Chiba S.
    Clin Exp Pharmacol Physiol; 1982 Jan; 9(6):587-94. PubMed ID: 7166002
    [Abstract] [Full Text] [Related]

  • 23. Cyclic-AMP and pancreatic bicarbonate secretion in response to secretin in dogs.
    Domschke S, Konturek SJ, Domschke W, Dembiński A, Thor P, Król R, Demling L.
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):773-9. PubMed ID: 1797
    [Abstract] [Full Text] [Related]

  • 24. Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.
    Kelso EJ, McDermott BJ, Silke B.
    Br J Pharmacol; 1993 Dec; 110(4):1387-94. PubMed ID: 8306078
    [Abstract] [Full Text] [Related]

  • 25. Rat pancreatic adenylate cyclase. IV. Effect of hormones and other agents on cyclic AMP level and enzyme release.
    Kempen JM, De Pont JJ, Bonting SL.
    Biochim Biophys Acta; 1977 Jan 24; 496(1):65-76. PubMed ID: 189833
    [Abstract] [Full Text] [Related]

  • 26. Direct and indirect stimulation of pancreatic exocrine secretion by neurotensin in anaesthetized dogs.
    Iwatsuki K, Horiuchi A, Ren LM, Chiba S.
    Clin Exp Pharmacol Physiol; 1991 Jul 24; 18(7):475-81. PubMed ID: 1914248
    [Abstract] [Full Text] [Related]

  • 27. [Role of "secondary transmitters" in the exocrine function of the pancreas].
    Domshke V, Konturek SIa, Domshke S.
    Fiziol Zh SSSR Im I M Sechenova; 1981 Mar 24; 67(3):423-32. PubMed ID: 6265294
    [Abstract] [Full Text] [Related]

  • 28. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R, Pyne NJ, Furman BL.
    Br J Pharmacol; 1995 Aug 24; 115(8):1486-92. PubMed ID: 8564209
    [Abstract] [Full Text] [Related]

  • 29. Differential actions of phosphodiesterase inhibitors on secretin- and vasoactive intestinal peptide-induced increases in chief cell cAMP.
    Raufman JP, Cosowsky L.
    Biochim Biophys Acta; 1988 Jul 29; 970(3):318-23. PubMed ID: 2456788
    [Abstract] [Full Text] [Related]

  • 30. Effects of ZSY-27, a synthesized phosphodiesterase inhibitor, on exocrine secretion and cyclic nucleotide concentration in the dog pancreas.
    Iwatsuki K, Horiuchi A, Chiba S.
    Clin Exp Pharmacol Physiol; 1987 Jul 29; 14(11-12):915-8. PubMed ID: 2834125
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of phosphodiesterase inhibitors on accumulation of cyclic AMP in isolated ventricular cardiomyocytes.
    Kelso EJ, McDermott BJ, Silke B.
    Biochem Pharmacol; 1995 Feb 14; 49(4):441-52. PubMed ID: 7872950
    [Abstract] [Full Text] [Related]

  • 32. Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments.
    Weiss RM, Wheeler MA.
    J Pharmacol Exp Ther; 1988 Nov 14; 247(2):630-4. PubMed ID: 2846825
    [Abstract] [Full Text] [Related]

  • 33. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A, Tenor H, Schudt C.
    Br J Pharmacol; 1995 Feb 14; 114(4):821-31. PubMed ID: 7539697
    [Abstract] [Full Text] [Related]

  • 34. Effects of substance P on pancreatic exocrine secretion stimulated by secretin, dopamine and cholecystokinin in dogs.
    Iwatsuki K, Yamagishi F, Chiba S.
    Clin Exp Pharmacol Physiol; 1986 Sep 14; 13(9):663-70. PubMed ID: 2433085
    [Abstract] [Full Text] [Related]

  • 35. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S.
    J Mol Cell Cardiol; 1996 Dec 14; 28(12):2491-9. PubMed ID: 9004165
    [Abstract] [Full Text] [Related]

  • 36. The effects of theophylline and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on protein secretion from rat parotid gland.
    Afari G, Tenenhouse A, Vachon C.
    Br J Pharmacol; 1982 Nov 14; 77(3):405-11. PubMed ID: 6291691
    [Abstract] [Full Text] [Related]

  • 37. Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes.
    Nicholson D, White TD, Sawynok J.
    Can J Physiol Pharmacol; 1991 Jun 14; 69(6):877-85. PubMed ID: 1717120
    [Abstract] [Full Text] [Related]

  • 38. Effects of synthesized phosphodiesterase inhibitors, DM 9278 and HWA 285, on pancreatic exocrine secretion of the dog.
    Yamagishi F, Homma N, Haruta K, Iwatsuki K, Chiba S.
    Jpn J Pharmacol; 1985 Oct 14; 39(2):131-6. PubMed ID: 3841375
    [Abstract] [Full Text] [Related]

  • 39. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC, Anderson N, Peachell PT.
    Br J Pharmacol; 1997 May 14; 121(2):287-95. PubMed ID: 9154339
    [Abstract] [Full Text] [Related]

  • 40. Pertussis toxin stimulates cholecystokinin-induced cyclic AMP formation but is without effect on secretagogue-induced calcium mobilization in exocrine pancreas.
    Willems PH, Tilly RH, de Pont JJ.
    Biochim Biophys Acta; 1987 Apr 22; 928(2):179-85. PubMed ID: 2436669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.